77 related articles for article (PubMed ID: 22104727)
1. Inhibition of activated Stat3 reverses drug resistance to chemotherapeutic agents in gastric cancer cells.
Huang S; Chen M; Shen Y; Shen W; Guo H; Gao Q; Zou X
Cancer Lett; 2012 Feb; 315(2):198-205. PubMed ID: 22104727
[TBL] [Abstract][Full Text] [Related]
2. Drug resistance via feedback activation of Stat3 in oncogene-addicted cancer cells.
Lee HJ; Zhuang G; Cao Y; Du P; Kim HJ; Settleman J
Cancer Cell; 2014 Aug; 26(2):207-21. PubMed ID: 25065853
[TBL] [Abstract][Full Text] [Related]
3. Exploring Novel Frontiers: Leveraging STAT3 Signaling for Advanced Cancer Therapeutics.
Adesoye T; Tripathy D; Hunt KK; Keyomarsi K
Cancers (Basel); 2024 Jan; 16(3):. PubMed ID: 38339245
[TBL] [Abstract][Full Text] [Related]
4. SOCS3 gene silencing does not occur through methylation and mutations in gastric cancer.
Al Saqri A; Malgundkar SH; Al Kindi F; Gupta I; Al Moundhri M; Tamimi Y
Hum Cell; 2022 Jul; 35(4):1114-1125. PubMed ID: 35596898
[TBL] [Abstract][Full Text] [Related]
5. STAT3 contributes to cisplatin resistance, modulating EMT markers, and the mTOR signaling in lung adenocarcinoma.
Morelli AP; Tortelli TC; Mancini MCS; Pavan ICB; Silva LGS; Severino MB; Granato DC; Pestana NF; Ponte LGS; Peruca GF; Pauletti BA; Dos Santos DFG; de Moura LP; Bezerra RMN; Leme AFP; Chammas R; Simabuco FM
Neoplasia; 2021 Sep; 23(10):1048-1058. PubMed ID: 34543857
[TBL] [Abstract][Full Text] [Related]
6. Isoforms of the p53 Family and Gastric Cancer: A Ménage à Trois for an Unfinished Affair.
Blanchet A; Bourgmayer A; Kurtz JE; Mellitzer G; Gaiddon C
Cancers (Basel); 2021 Feb; 13(4):. PubMed ID: 33671606
[TBL] [Abstract][Full Text] [Related]
7. Circular RNA circVAPA promotes chemotherapy drug resistance in gastric cancer progression by regulating miR-125b-5p/STAT3 axis.
Deng P; Sun M; Zhao WY; Hou B; Li K; Zhang T; Gu F
World J Gastroenterol; 2021 Feb; 27(6):487-500. PubMed ID: 33642823
[TBL] [Abstract][Full Text] [Related]
8. Targeting Janus Kinases and Signal Transducer and Activator of Transcription 3 to Treat Inflammation, Fibrosis, and Cancer: Rationale, Progress, and Caution.
Bharadwaj U; Kasembeli MM; Robinson P; Tweardy DJ
Pharmacol Rev; 2020 Apr; 72(2):486-526. PubMed ID: 32198236
[TBL] [Abstract][Full Text] [Related]
9. Adapting and Surviving: Intra and Extra-Cellular Remodeling in Drug-Resistant Gastric Cancer Cells.
Russi S; Verma HK; Laurino S; Mazzone P; Storto G; Nardelli A; Zoppoli P; Calice G; La Rocca F; Sgambato A; Lucci V; Falco G; Ruggieri V
Int J Mol Sci; 2019 Jul; 20(15):. PubMed ID: 31370155
[TBL] [Abstract][Full Text] [Related]
10. Proton pump inhibitor: The dual role in gastric cancer.
Joo MK; Park JJ; Chun HJ
World J Gastroenterol; 2019 May; 25(17):2058-2070. PubMed ID: 31114133
[TBL] [Abstract][Full Text] [Related]
11. STAT3 rs4796793 contributes to lung cancer risk and clinical outcomes of platinum-based chemotherapy.
Gong WJ; Ma LY; Hu L; Lv YN; Huang H; Xu JQ; Huang DD; Liu RJ; Han Y; Zhang Y; Shi SJ; Wu SL
Int J Clin Oncol; 2019 May; 24(5):476-484. PubMed ID: 30689078
[TBL] [Abstract][Full Text] [Related]
12. S1PR1 predicts patient survival and promotes chemotherapy drug resistance in gastric cancer cells through STAT3 constitutive activation.
Song S; Min H; Niu M; Wang L; Wu Y; Zhang B; Chen X; Liang Q; Wen Y; Wang Y; Yi L; Wang H; Gao Q
EBioMedicine; 2018 Nov; 37():168-176. PubMed ID: 30316864
[TBL] [Abstract][Full Text] [Related]
13. Novel imidazopyridine suppresses STAT3 activation by targeting SHP-1.
Su JC; Chang CH; Wu SH; Shiau CW
J Enzyme Inhib Med Chem; 2018 Dec; 33(1):1248-1255. PubMed ID: 30261753
[TBL] [Abstract][Full Text] [Related]
14. Influence of TS (rs34743033) and RUNX1 (rs2014300) gene polymorphisms on survival outcomes of fluorouracil-based chemotherapy in Chinese advanced gastric cancer patients.
Han R; Wei J; Zhang H; Su X; Chu X; Chen Y; Gong Y; Wang X; Shi J; Chen J
Cancer Manag Res; 2018; 10():1429-1437. PubMed ID: 29922087
[TBL] [Abstract][Full Text] [Related]
15. Parthenolide facilitates apoptosis and reverses drug-resistance of human gastric carcinoma cells by inhibiting the STAT3 signaling pathway.
Li H; Lu H; Lv M; Wang Q; Sun Y
Oncol Lett; 2018 Mar; 15(3):3572-3579. PubMed ID: 29467878
[TBL] [Abstract][Full Text] [Related]
16. Establishment of malignantly transformed dendritic cell line SU3-ihDCTC induced by Glioma stem cells and study on its sensitivity to resveratrol.
Fei X; Wang A; Wang D; Meng X; Ma J; Hong L; Qin R; Wang A; Dong J; Huang Q; Wang Z
BMC Immunol; 2018 Feb; 19(1):7. PubMed ID: 29390972
[TBL] [Abstract][Full Text] [Related]
17. Inhibition of two gastric cancer cell lines induced by fucoxanthin involves downregulation of Mcl-1 and STAT3.
Yu RX; Yu RT; Liu Z
Hum Cell; 2018 Jan; 31(1):50-63. PubMed ID: 29110251
[TBL] [Abstract][Full Text] [Related]
18. Liquiritin induces apoptosis and autophagy in cisplatin (DDP)-resistant gastric cancer cells in vitro and xenograft nude mice in vivo.
Wei F; Jiang X; Gao HY; Gao SH
Int J Oncol; 2017 Nov; 51(5):1383-1394. PubMed ID: 29048624
[TBL] [Abstract][Full Text] [Related]
19. Targeting phosphorylation of STAT3 delays tumor growth in HPV-negative anal squamous cell carcinoma mouse model.
Bu LL; Li YC; Yu GT; Liu JF; Deng WW; Zhang WF; Zhang L; Sun ZJ
Sci Rep; 2017 Jul; 7(1):6629. PubMed ID: 28747781
[TBL] [Abstract][Full Text] [Related]
20. Sphingosine-1-Phosphate Receptor-1 Promotes Environment-Mediated and Acquired Chemoresistance.
Lifshitz V; Priceman SJ; Li W; Cherryholmes G; Lee H; Makovski-Silverstein A; Borriello L; DeClerck YA; Yu H
Mol Cancer Ther; 2017 Nov; 16(11):2516-2527. PubMed ID: 28716816
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
